Table 4.
Training initiatives provided by EU HTA agencies/organizations at national level.
| Country | Promoting agency/organization | Training initiatives title | Year of delivery | Type of training initiative | Target | Topic | Technology addressed in the course | Language |
|---|---|---|---|---|---|---|---|---|
| Austria | AIHTA—Austrian Institute for Health Technology Assessment | 1st Workshop of the EUnetHTA Task Force on HTA and Medical Devices (14) | 2018 | Workshop | HTA professionals | HTA regulation and legal framework | Medical devices | English |
| Workshop series: Ethik and HTA (15) | 2017 | Workshop | HTA professionals, health policy decision-makers, experts in applied ethics in HTA | Ethical methodology in HTA | Health technology | German | ||
| Workshop Health Technology Assessment (16) | 2009 | Workshop | Healthcare decision makers | HTA methodology and application | Health technology | English/German | ||
| UMIT— University for Health Sciences, Medical Informatics and Technology |
Modeling Approaches for HTA: A Practical Hands-on Workshop (17) | 2021 | Three-day course | Healthcare and health policy organizations, national HTA Agencies; Pharmaceutical and medical device industry; Academia and research institutions; Health insurances/sickness funds; Consultancy organizations. |
HTA methodology | Health technology | English | |
| Introduction to health technology assessment HTADS—program on health technology (1)assessment and decision sciences (18) | 2021 | Four-day course | Healthcare and health policy organizations, national HTA Agencies; Pharmaceutical and medical device industry -Academia and research institutions -Health insurances/sickness funds-Consultancy organizations |
HTA methodology | Health technology | English | ||
| Causal inference for assessing effectiveness in real world data and clinical trials: a practical hands-on workshop (19) | 2021 | Five-day course | Healthcare and health policy organizations, national HTA agencies regulatory agencies; pharmaceutical and medical device industry, academia and research institutions, health insurances, consultancy organizations. | Clinical utility (effectiveness) | Health technology | English | ||
| GOG—Gesundheit Österreich GmbH/Geschäftsbereich | 3rd summer school pharmaceutical pricing and reimbursement policies (20) | 2018 | Summer school/5 days training course | Professionals of public and non-for profit institutions working in the field of pricing and reimbursement of medicines | Economic evaluation | Drugs | English | |
| 2nd summer school pharmaceutical pricing and reimbursement policies (21) | 2017 | Summer school/5 days training course | Professionals of public and non-for profit institutions working in the field of pricing and reimbursement of medicines | Economic evaluation | Drugs | English | ||
| 1st summer school pharmaceutical pricing and reimbursement policies (22) | 2016 | Summer school/5 days training course | Professionals of public and non-for profit institutions working in the field of pricing and reimbursement of medicines | Economic evaluation | Drugs | English, and simultaneous translation into Russian | ||
| Belgium | KCE— belgian health care centre |
HTA workshop | collaboration between HTA agencies in practice: learning from actual experiences (23) | 2010 | Workshop | HTA agencies | HTA methodology | Health technology | English |
| Italy | UCSC Gemelli | Health impact assessment e health technology assessment (24) |
2019 | In attendance course | Researchers and health managers | HTA and HIA methodology | Health technology | Italian |
| Health technology assessment (25) | 2016 | In attendance course | Healthcare professionals | HTA methodology and application | Health technology | Italian | ||
| Netherlands | Erasmus Universiteit Rotterdam |
MOOC health technology assessment (26) | N.A.* | Massive open online course (MOOC) | Health economics policy and law master students, health economics master students and the research master students | HTA methodology and application | Health technology | English |
| Portugal | INFARMED- National Authority of Medicines and Health Products |
Health technology assessment training program (68) | 2016 | Online course | Professionals from government and health insurance funds, HTA bodies, public and private payers and health plans, industry, academia, and patient group representatives; | HTA methodology and application | Health technology | English |
| Pharmacovigilance course (Curso de atualização em farmacovigilância) (28) | 2020 | Online course | Health professionals | Clinical utility (safety) | Drugs | Portuguese | ||
| Curso Pós-Graduado De Atualização: Assessing Therapeutic Efectiveness In Drug Lifecycle (29) | 2019 | In attendance course | Academics and health care professionals, PhD students and master students | Clinical utility (effectiveness) | Drugs | English | ||
| Artificial intelligence in health: governance, accountability and decision-making (Inteligência artificial em saúde: governança, responsabilidade e tomada de decisão) (30) | 2019 | In attendance course | Higher education professionals and students in the fields of health, social sciences, management, computer science and engineering. | Ethical and legal aspects | Digital health technology | Portuguese | ||
| Introduction to value-based health care management (Introdução à Gestão de Cuidados de Saúde Baseada em Valor) (31) | 2020 | b-learning course | Healthcare professionals | HTA application and Value Based Healthcare | Health technology | English | ||
| Romania | NSPHMPDB- The National School of Public Health, Management and Professional Development |
Training programs in both public health and management (32) | N.A.* | In attendance Courses | All categories of staff in public health and management and other areas of the health system | HTA methodology and application | Health technology | Romanian |
| Spain | AEMPS- La Agencia Española de Medicamentos y Productos Sanitarios |
Technical training of biosimilar medicines (Capacitación técnica de medicamentos biosimilares) (33) | 2020 | Online course | Specialized and qualified representatives from seventeen Ibero-American countries. | Legal and regulatory processes | Drugs | Spanish |
| 3rd training course in standards of good clinical practice for independent researchers (3° curso de formación en normas de buena práctica clínica para investigadores independientes) (34) | 2009 | In attendance course | Clinical researchers | Ethical and legal aspects | Health technology and drugs | Spanish | ||
| Practical course for conducting pharmacoepideomyology studies with the bifap database (curso practico para la realización de estudios de farmacoepidemiologia con la base de datos bifap) (35) | 2016 | In attendance course | Public researchers | Clinical utility (safety) | Drugs | Spanish | ||
| FIISC—Funcanis_Fundación Canaria de Investigación Sanitaria | Application of molecular biology in the diagnosis and follow-up of chronic lymphocytic leukemia (Aplicación de la Biología molecular en el diagnóstico y seguimiento de la Leucemia Linfocítica crónica) (36) | 2019 | In attendance Course | Graduates and certified lab technicians | HTA application | Genetics, molecular biology and mass sequencing | Spanish | |
| BIOEF— Basque Foundation for Health Innovation and Research |
UPV/EHU summer course on health research and innovation (37) | 2012 | In attendance course | Healthcare professionals, clinical researchers | HTA applications | Health technology | Spanish | |
| AETSA— Andalusian HTA Agency |
Introduction of the economic assessment in the health technology assessment (38) | 2016 | Workshop | Andalusian public health system (SSPA) professionals interested in financial evaluation | Economic evaluation | Health technology and drugs | Spanish | |
| United Kingdom | NICE | Seminars (39) | N.A.* | Seminars; Advanced workshops | Pharmaceutical, medical technology or cell and gene therapy sectors | HTA applications | Health technology, drugs, gene therapy | English |
| AWTTC— All Wales Therapeutics and Toxicology Centre |
AWMSG training day (40) | 2019 | In attendance course | Members and deputies of AWMSG; new medicines group and the all wales prescribing advisory group; medicines and therapeutics committees | Economic evaluation | Orphan medicines | English | |
| Adverse drug reactions: reporting makes medicines safer (41) | N.A.* | Online course | Healthcare professionals | Clinical utility (Safety) | Drugs | English | ||
| HTW— Health Technology Wales |
Health technology assessment and economics (42) | 2019 | Workshop | NHS front line staff; NHS Financial, Medical and Planning Directors; Care commissioners; Workforce managers; Patients; Members of the public; Academia; Technology developers; Industry representatives | Economic evaluation | Health technology | English | |
| Value in health week (43) | 2020 | Webinar | All stakeholders | HTA dimensions and applications | Health technology | English |
*
The year in which training initiative was provided was Not Available (N.A.).